Vancomycin Dosing in a Dialysis Patient with Suspected Sepsis
Mr. Rahman, a 62-year-old man weighing 70 kg, is admitted to a tertiary hospital in Dhaka with fever (38.9 °C), hypotension (BP 88/54 mmHg), and a tunneled catheter. He has end-stage renal disease and receives hemodialysis three times weekly (Monday, Wednesday, Friday), each session lasting 4 hours with a high-flux dialyzer. Blood cultures are drawn and empiric vancomycin plus cefepime are ordered. The pharmacy resident proposes 15 mg/kg IV every 12 hours. The nephrologist asks you to review the regimen. Serum creatinine is 6.8 mg/dL; the patient is anuric. The hospital has no continuous renal replacement therapy and no AUC-guided dosing software, but can draw trough levels before the next dose. The next dialysis session is in 10 hours.
1. Critically evaluate the resident's proposed vancomycin regimen and design a defensible loading and maintenance plan for this patient.
Read the worked answer
The resident's regimen is unsafe. Vancomycin is eliminated almost entirely by glomerular filtration, and this anuric patient on intermittent hemodialysis will accumulate drug rapidly. A 15 mg/kg dose every 12 hours would produce troughs far above the 15–20 mg/L target and risk nephrotoxicity (less relevant here) and, more importantly, ototoxicity and infusion reactions.
Loading dose: Because volume of distribution is roughly 0.7 L/kg (about 49 L), a loading dose of 15–20 mg/kg actual body weight is appropriate to rapidly achieve therapeutic concentrations in sepsis. For 70 kg, give 1000–1400 mg IV infused over at least 60 minutes. A loading dose is not renally adjusted because it fills the distribution volume, not the elimination pathway.
Maintenance dosing: With thrice-weekly high-flux dialysis, a practical approach is to give a dose after each dialysis session, typically 500–1000 mg (roughly 7.5–15 mg/kg), because high-flux membranes clear substantial vancomycin. Alternatively, redosing when a pre-dialysis trough falls below 15 mg/L is defensible.
Monitoring: Draw a trough immediately before the next dose (or pre-dialysis). Target 15–20 mg/L for serious MRSA infection. Document timing precisely, because levels drawn during or shortly after dialysis will be falsely low. Coordinate with the dialysis unit so the dose is given after the session.
2. The patient's blood culture grows methicillin-resistant Staphylococcus aureus. Two days later he develops increasing confusion. What therapeutic and monitoring adjustments would you recommend, and what is the rationale?
Read the worked answer
Persistent bacteremia and new confusion in a catheter-dependent dialysis patient raise concern for uncontrolled source (catheter-related bloodstream infection), possible endocarditis, and vancomycin failure. The pharmacist should recommend:
Source control: The tunneled catheter is the likely source. Urgent infectious-disease and nephrology input is needed regarding catheter removal or exchange. Antimicrobials alone rarely cure an infected tunneled catheter.
Assess vancomycin exposure: Obtain a pre-dialysis trough and consider whether levels are therapeutic. If the MIC is 2 mg/L or the patient is not responding, guidelines favor switching to daptomycin (dosed after dialysis, since it is renally cleared) or adding an anti-staphylococcal beta-lactam depending on susceptibility. Daptomycin is inactivated by pulmonary surfactant, so it is inappropriate if pneumonia is suspected.
Echocardiography: Transthoracic echocardiography should be arranged; if negative and suspicion remains high, transesophageal echocardiography is preferred. Endocarditis would mandate a longer course (typically 6 weeks) and often combination therapy.
Monitoring: Track temperature, blood pressure, repeat cultures, and vancomycin levels. Watch for red man syndrome with rapid infusion and for ototoxicity. Ensure cefepime dose is also renal-adjusted, since cefepime accumulation can itself cause neurotoxicity and confusion.